Skip to content

EPIMED SOLUTIONS BELGIUM

Active
Private limited companyfounded 2017active for 8 yearsMarsveldplein 5, 1050 Elsene, BelgiumKBO/BCE: BE 0684.772.092
Summary

EPIMED SOLUTIONS BELGIUM has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €381,651 and a net result of €26,974. Equity has been growing by about 22% per year since 2018. Its solvency ranks better than 87% of 324 sector peers (NACE 58, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 17-11-2017 Normal situation
Registered office
397 active companies are registered at this address 31 started in the 12 months before. Source: KBO register, as of 2 November 2026.
Activity
Other software publishing NACE 58290and 3 others
Establishment unit
2.276.833.191 1050 Elsene, since 17-11-2017
Financial year end
31 December
Peppol
Reachable since 17-07-2025

Board and ownership

Holdings
Shares in 1 company EPM MEDICAL DATA SOLUTIONS PORTUGAL, UNIPESSOAL LDA

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€196,165
▼ 57.6%
Turnover
≈ €500,000
estimated
Profit
€26,974
▼ 33.0%
Equity
€381,651
▲ 7.6%
Total assets
€449,885
▼ 29.8%
Employees on 31-12-2025
1
▼ 50.0%
Score breakdownraises risk1 of the last 3 accounts latelowers riskLiquidity: current ratio 6.56, cash €66,959, halvedSector: Publishing activities (NACE 58)Equity €381,651 (84.8% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 66% of micro companies in publishing (NACE 58)
Financial strength · tick: 2024
Strong
Solvency 100+20
equity 84.8% of total assets
Liquidity 65-15
short-term debt 15.2% · cash 14.9%
Profitability 76-1
return on assets 6.0%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (1,282 companies, NACE 58, micro)
Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025highest value 08-2025: 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026lowest value 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €35,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.56 (2.57 in 2024), above the usual 1.5. Short-term debt is 15.2% and cash 14.9% of total assets. 15.2% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 58, micro). It does better than 87% of them on solvency, 59% on liquidity, 58% on profitability and 59% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 6.56, cash €66,959, halved
NBB · annual accounts
lowers risk · Sector: Publishing activities (NACE 58)
KBO
lowers risk · Equity €381,651 (84.8% of total assets)
NBB · annual accounts
raises risk · 1 of the last 3 accounts late
NBB · filings
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
16 days early
2024
20 days early
2023
49 days late
2022
28 days late
2021
30 days late
2020
32 days early
2019
89 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 18 days after the deadline. In the sector (NACE 58), the median for financial year 2024 was 7 days before the deadline, and 37% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 5 accounts filed within 44 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 86% of companies in publishingsector median 45.9% · 324 companies 84.8% View

Recent changes

  1. · Gazette deed Capital increase of €711,000 to €729,600Resignation: Bujokas Da Rosa Renata (director) · Reappointment: Bujokas Da Rosa Renata (director)
  2. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as EPIMED SOLUTIONS BELGIUM: other software publishing (NACE 58290). They are comparable in size and age: total assets between €298,000 and €522,000, founded between 2013 and 2021.

CompanyTotal assetsGross margin
EPIMED SOLUTIONS BELGIUM Elsene€449,885€196,165
MOOZE WEST Genk€522,473€251,283
Cloud Worx Brugge€384,174€318,958
WIKIFLOW Anhée€497,282€402,789
PIDGON Koekelare€448,938€205,340
IT-Rex Consulting Diest€297,513€281,525
Intelli-Select Etterbeek€511,285€302,736
Full comparison

Key facts about EPIMED SOLUTIONS BELGIUM

What is the company number of EPIMED SOLUTIONS BELGIUM?
The company number of EPIMED SOLUTIONS BELGIUM is 0684.772.092. The VAT number is the same number with BE in front: BE 0684.772.092.
Where is EPIMED SOLUTIONS BELGIUM based?
The registered office is at Marsveldplein 5, 1050 Elsene.Company details
What does EPIMED SOLUTIONS BELGIUM do?
According to the KBO register, the main activity is other software publishing (NACE 58290).
What is the legal form of EPIMED SOLUTIONS BELGIUM?
The legal form of EPIMED SOLUTIONS BELGIUM is Private limited company (BV).
When was EPIMED SOLUTIONS BELGIUM founded?
EPIMED SOLUTIONS BELGIUM was founded on 17-11-2017.
Is EPIMED SOLUTIONS BELGIUM still active?
Yes, EPIMED SOLUTIONS BELGIUM is an active enterprise in the KBO register.
How many employees does EPIMED SOLUTIONS BELGIUM have?
EPIMED SOLUTIONS BELGIUM had an average of 4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of EPIMED SOLUTIONS BELGIUM?
The turnover in financial year 2025 is ≈ €500,000. This figure is estimated from the gross margin of €196,165 and 1,647 comparable companies of the same size. It probably lies between €310,000 and €940,000. It is a rough estimate.
Is EPIMED SOLUTIONS BELGIUM profitable?
In financial year 2025, EPIMED SOLUTIONS BELGIUM made a profit of €26,974.
Where can I find the annual accounts of EPIMED SOLUTIONS BELGIUM?
EPIMED SOLUTIONS BELGIUM filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of EPIMED SOLUTIONS BELGIUM due?
EPIMED SOLUTIONS BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.